Terms: = Kidney tumors AND TERT, EST2, Q8NG46, Q8N6C3, Q2XS35, O14783, O14746, 7015, hEST2, TCS1, TRT, TP2
91 results:
1. Synthesis and Preclinical Evaluation of PSMA-Targeted
Santos JF; Braz MT; Raposinho P; Cleeren F; Cassells I; Leekens S; Cawthorne C; Mendes F; Fernandes C; Paulo A
Mol Pharm; 2024 Jan; 21(1):216-233. PubMed ID: 37992229
[TBL] [Abstract] [Full Text] [Related]
2. Evaluation of an institutional series of low-grade oncocytic tumor (LOT) of the kidney and review of the mutational landscape of LOT.
Ricci C; Ambrosi F; Franceschini T; Giunchi F; Grillini A; Franchini E; Grillini M; Schiavina R; Massari F; Mollica V; Tateo V; Bianchi FM; Bianchi L; Droghetti M; Maloberti T; Tallini G; Colecchia M; Acosta AM; Lobo J; Trpkov K; Fiorentino M; de Biase D
Virchows Arch; 2023 Nov; 483(5):687-698. PubMed ID: 37845471
[TBL] [Abstract] [Full Text] [Related]
3. Development of Radiopharmaceuticals for NPY Receptor-5 (Y5) Nuclear Imaging in tumors by Synthesis of Specific Agonists and Investigation of Their Binding Mode.
Bodin S; Peuker LC; Jestin E; Alves ID; Velasco V; Ait-Arsa I; Schollhammer R; Lamare F; Vimont D; MacGrogan G; Hindié E; Beck-Sickinger AG; Morgat C
Bioconjug Chem; 2023 Nov; 34(11):2014-2021. PubMed ID: 37556437
[TBL] [Abstract] [Full Text] [Related]
4. Single-Time-Point Imaging for Dosimetry After [
Wang C; Peterson AB; Wong KK; Roseland ME; Schipper MJ; Dewaraja YK
J Nucl Med; 2023 Sep; 64(9):1463-1470. PubMed ID: 37500260
[TBL] [Abstract] [Full Text] [Related]
5. tert Promoter Mutations Frequency Across Race, Sex, and Cancer Type.
El Zarif T; Machaalani M; Nawfal R; Nassar AH; Xie W; Choueiri TK; Pomerantz M
Oncologist; 2024 Jan; 29(1):8-14. PubMed ID: 37462445
[TBL] [Abstract] [Full Text] [Related]
6. Chromophobe Renal Cell Carcinoma with Sarcomatoid Differentiation: Clinicopathologic Correlation and Molecular Findings.
Gama A; Xu H; Yang XJ; Choy B
Int J Surg Pathol; 2024 Feb; 32(1):11-16. PubMed ID: 37063043
[No Abstract] [Full Text] [Related]
7. Targeted α-Therapy Using
Ertveldt T; Krasniqi A; Ceuppens H; Puttemans J; Dekempeneer Y; Jonghe K; Mey W; Lecocq Q; Vlaeminck Y; Awad RM; Goyvaerts C; Veirman K; Morgenstern A; Bruchertseifer F; Keyaerts M; Devoogdt N; D'Huyvetter M; Breckpot K
J Nucl Med; 2023 May; 64(5):751-758. PubMed ID: 37055223
[TBL] [Abstract] [Full Text] [Related]
8. Clinical and genomic features in patients with second primary glioblastoma following first primary renal cell carcinoma.
Zhang GT; Liu Q; Zuo FX; Liu HJ; Wang SQ; Yuan Q; Liu AS; Hu K; Meng XL; Wang WJ; Qian HP; Wan JH; Cai HQ
BMC Cancer; 2023 Jan; 23(1):104. PubMed ID: 36717819
[TBL] [Abstract] [Full Text] [Related]
9. Synthesis and biological evaluation of tert-butyl ester and ethyl ester prodrugs of L-γ-methyleneglutamic acid amides for cancer.
Khan MIH; Mahdi F; Penfornis P; Akins NS; Hossain MI; Kim SJ; Sulochana SP; Adam AT; Tran TD; Tan C; Paolo Claudio P; Paris JJ; Le HV
Bioorg Med Chem; 2023 Jan; 78():117137. PubMed ID: 36603398
[TBL] [Abstract] [Full Text] [Related]
10. Gonadal Function in Male Patients With Metastatic Renal Cell Cancer Treated With Sunitinib.
Volta AD; Delbarba A; Valcamonico F; Cappelli C; Caramella I; Bergamini M; Ferlin A; Berruti A
In Vivo; 2023; 37(1):410-416. PubMed ID: 36593059
[TBL] [Abstract] [Full Text] [Related]
11. Genetic changes associated with relapse in favorable histology Wilms tumor: A Children's Oncology Group AREN03B2 study.
Gadd S; Huff V; Skol AD; Renfro LA; Fernandez CV; Mullen EA; Jones CD; Hoadley KA; Yap KL; Ramirez NC; Aris S; Phung QH; Perlman EJ
Cell Rep Med; 2022 Jun; 3(6):100644. PubMed ID: 35617957
[TBL] [Abstract] [Full Text] [Related]
12. Phase I study of [
Thivat E; Rouanet J; Auzeloux P; Sas N; Jouberton E; Levesque S; Billoux T; Mansard S; Molnar I; Chanchou M; Fois G; Maigne L; Chezal JM; Miot-Noirault E; D'Incan M; Durando X; Cachin F
BMC Cancer; 2022 Apr; 22(1):417. PubMed ID: 35428211
[TBL] [Abstract] [Full Text] [Related]
13. Methyl-tert-butyl ether (MTBE): integration of rat and mouse carcinogenicity data with mode of action and human and rodent bioassay dosimetry and toxicokinetics indicates MTBE is not a plausible human carcinogen.
Bus JS; Gollapudi BB; Hard GC
J Toxicol Environ Health B Crit Rev; 2022 May; 25(4):135-161. PubMed ID: 35291916
[TBL] [Abstract] [Full Text] [Related]
14. Adult Wilms Tumor: Genetic Evidence of Origin of a Subset of Cases From Metanephric Adenoma.
Argani P; Tickoo SK; Matoso A; Pratilas CA; Mehra R; Tretiakova M; Sibony M; Meeker AK; Lin MT; Reuter VE; Epstein JI; Gagan J; Palsgrove DN
Am J Surg Pathol; 2022 Jul; 46(7):988-999. PubMed ID: 35184066
[TBL] [Abstract] [Full Text] [Related]
15. Solitary Fibrous Tumor With Extensive Epithelial Inclusions.
Zhao M; He H; Cao D; Fan D; Xu M; Zhang X; Ru G
Am J Clin Pathol; 2022 Jul; 158(1):35-46. PubMed ID: 34999741
[TBL] [Abstract] [Full Text] [Related]
16. Papillary renal cell carcinoma: a single institutional study of 199 cases addressing classification, clinicopathologic and molecular features, and treatment outcome.
Murugan P; Jia L; Dinatale RG; Assel M; Benfante N; Al-Ahmadie HA; Fine SW; Gopalan A; Sarungbam J; Sirintrapun SJ; Hakimi AA; Russo P; Chen YB; Tickoo SK; Reuter VE
Mod Pathol; 2022 Jun; 35(6):825-835. PubMed ID: 34949764
[TBL] [Abstract] [Full Text] [Related]
17. Differences in genomic profile of high-grade urothelial carcinoma according to tumor location.
Park CK; Cho NH
Urol Oncol; 2022 Mar; 40(3):109.e1-109.e9. PubMed ID: 34663543
[TBL] [Abstract] [Full Text] [Related]
18. Targeted Delivery of Cabazitaxel Using Cyclic Cell-Penetrating Peptide and Biomarkers of Extracellular Matrix for Prostate and Breast Cancer Therapy.
Park SE; El-Sayed NS; Shamloo K; Lohan S; Kumar S; Sajid MI; Tiwari RK
Bioconjug Chem; 2021 Aug; 32(8):1898-1914. PubMed ID: 34309357
[TBL] [Abstract] [Full Text] [Related]
19. Molecular Characterization of Muellerian tumors of the Urinary Tract.
Ortiz-Brüchle N; Wucherpfennig S; Rose M; Garczyk S; Bertz S; Hartmann A; Reis H; Szarvas T; Kiss A; Bremmer F; Golz R; Knüchel R; Gaisa NT
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34200508
[TBL] [Abstract] [Full Text] [Related]
20. Urothelial carcinoma of the graft kidney with molecular analyses: a rare case report.
Chen JM; Kenneth Haines G; Lam W; Reddy A; Mehrotra M; Houldsworth J; Si Q
Diagn Pathol; 2021 Jun; 16(1):53. PubMed ID: 34127009
[TBL] [Abstract] [Full Text] [Related]
[Next]
